We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Patterson Companies & Heartland Dental Form Partnership
Read MoreHide Full Article
St. Paul, MN-based Patterson Companies Inc. (PDCO - Free Report) , a leading distributor and seller of dental and animal health products, recently announced that it has been selected as a distribution partner by Heartland Dental, the largest dental support organization (DSO) in the U.S. Notably, the partnership is expected to be effective from Jan 1, 2017.
The companies are believed to bring in ‘best-in-class products and solutions to the dentists’ with a superior combination of sales, service and exclusive technical expertise in the dental market.
Per management, the latest development would exclusively help the Patterson Dental platform to strengthen its hold and gain a leading position in the global markets. The strategic partnership also fortifies Heartland’s market position in the DSO space, as the company is about to leverage from Patterson’s expertise in logistics, technical service, ecommerce and ancillary technologies.
Patterson Dental has been a leading platform in enhancing customer experience in dental markets. Notably, the company recently adopted the ‘go-to-market’ strategy in its dental platform to address changing marketplace and customer demand. In fact, the sales-force realignment in this platform is another notable development for Patterson Companies in the recent past.
A glimpse at the last reported quarter (first-quarter fiscal 2017) reveals that sales at the Dental platform represented 43% of total sales and decreased 3.5% to $555 million approximately (up 2.1% at constant currency) on a year-over-year basis. In our view, Patterson Companies is exclusively trying to focus on its core dental business by forming strategic partnerships like these to perform better in the coming quarters.
We believe Patterson Companies is set to gain significant market traction in the coming quarters, taking the global market sentiments into consideration. In this regard, the global dental consumable market is forecasted to reach a worth of $35.35 billion by 2021, growing at a CAGR of 6.8%, as per a research by ‘Markets And Markets’.
Zacks Rank & Key Picks
Currently, Patterson Companies has a Zacks Rank #4 (Sell).
Better-ranked stocks in the broader medical sector include Cepheid Inc. , Healthways Inc. and PRA Health Sciences Inc. . All the three stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Cepheid has a long-term expected earnings growth rate of approximately 21.3%. Notably, the stock represents an impressive year-to-date return of 44.4%.
Healthways has a long-term expected earnings growth rate of 13.3%. The company posted a stupendous year-to-date return of 94.3%.
PRA Health Sciences has an expected earnings growth of 18%. The company posted a promising year-to-date return of almost 25.3%.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Patterson Companies & Heartland Dental Form Partnership
St. Paul, MN-based Patterson Companies Inc. (PDCO - Free Report) , a leading distributor and seller of dental and animal health products, recently announced that it has been selected as a distribution partner by Heartland Dental, the largest dental support organization (DSO) in the U.S. Notably, the partnership is expected to be effective from Jan 1, 2017.
The companies are believed to bring in ‘best-in-class products and solutions to the dentists’ with a superior combination of sales, service and exclusive technical expertise in the dental market.
Per management, the latest development would exclusively help the Patterson Dental platform to strengthen its hold and gain a leading position in the global markets. The strategic partnership also fortifies Heartland’s market position in the DSO space, as the company is about to leverage from Patterson’s expertise in logistics, technical service, ecommerce and ancillary technologies.
Patterson Dental has been a leading platform in enhancing customer experience in dental markets. Notably, the company recently adopted the ‘go-to-market’ strategy in its dental platform to address changing marketplace and customer demand. In fact, the sales-force realignment in this platform is another notable development for Patterson Companies in the recent past.
PATTERSON COS Price
PATTERSON COS Price | PATTERSON COS Quote
Our Take
A glimpse at the last reported quarter (first-quarter fiscal 2017) reveals that sales at the Dental platform represented 43% of total sales and decreased 3.5% to $555 million approximately (up 2.1% at constant currency) on a year-over-year basis. In our view, Patterson Companies is exclusively trying to focus on its core dental business by forming strategic partnerships like these to perform better in the coming quarters.
We believe Patterson Companies is set to gain significant market traction in the coming quarters, taking the global market sentiments into consideration. In this regard, the global dental consumable market is forecasted to reach a worth of $35.35 billion by 2021, growing at a CAGR of 6.8%, as per a research by ‘Markets And Markets’.
Zacks Rank & Key Picks
Currently, Patterson Companies has a Zacks Rank #4 (Sell).
Better-ranked stocks in the broader medical sector include Cepheid Inc. , Healthways Inc. and PRA Health Sciences Inc. . All the three stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Cepheid has a long-term expected earnings growth rate of approximately 21.3%. Notably, the stock represents an impressive year-to-date return of 44.4%.
Healthways has a long-term expected earnings growth rate of 13.3%. The company posted a stupendous year-to-date return of 94.3%.
PRA Health Sciences has an expected earnings growth of 18%. The company posted a promising year-to-date return of almost 25.3%.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>